A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Female Breast Carcinoma|Female Ductal Carcinoma In Situ
Interventions: DRUG: Fulvestrant
Sponsor: Atossa Therapeutics, Inc.